PROTAGONIST THERAPEUTICS INC's ticker is PTGX and the CUSIP is 74366E102. A total of 144 filers reported holding PROTAGONIST THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.37 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,185,264 | -20.4% | 71,059 | +9.7% | 0.00% | 0.0% |
| Q2 2023 | $1,489,894 | 0.0% | 64,778 | 0.0% | 0.00% | 0.0% |
| Q1 2023 | $1,489,894 | -99.4% | 64,778 | +137.5% | 0.00% | – |
| Q3 2022 | $229,928,000 | -11.0% | 27,275 | -16.5% | 0.00% | – |
| Q2 2022 | $258,372,000 | -66.6% | 32,664 | 0.0% | 0.00% | – |
| Q1 2022 | $773,483,000 | -30.8% | 32,664 | 0.0% | 0.00% | – |
| Q4 2021 | $1,117,109,000 | +128.4% | 32,664 | +18.4% | 0.00% | – |
| Q3 2021 | $489,037,000 | -60.5% | 27,598 | 0.0% | 0.00% | -100.0% |
| Q2 2021 | $1,238,598,000 | +91.3% | 27,598 | +10.4% | 0.00% | – |
| Q1 2021 | $647,500,000 | +163.3% | 25,000 | +104.9% | 0.00% | – |
| Q4 2020 | $245,952,000 | – | 12,200 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JOHNSON & JOHNSON | 2,449,183 | $56,331,209 | 18.32% |
| Kynam Capital Management, LP | 1,375,000 | $31,625,000 | 4.08% |
| BVF INC/IL | 3,775,900 | $86,845,700 | 3.18% |
| Cormorant Asset Management, LP | 1,700,000 | $39,100 | 2.58% |
| RTW INVESTMENTS, LP | 4,600,799 | $105,818,377 | 2.20% |
| Ghost Tree Capital, LLC | 225,000 | $5,175,000 | 1.53% |
| 683 Capital Management, LLC | 791,000 | $18,193,000 | 1.36% |
| Ikarian Capital, LLC | 211,400 | $4,862,200 | 1.10% |
| Ikarian Capital, LLC | 211,400 | $4,862,200 | 1.10% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 105,486 | $2,426,178 | 1.00% |